A critical review of antibiotic prophylaxis in severe acute pancreatitis

American Journal of Surgery

Volumn 172, Issue 6 A, 1996, Pages 38s-43s

  Barie, Philip S ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; CEFOTAXIME; CEFTIZOXIME; CEPHALOSPORIN DERIVATIVE; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; METRONIDAZOLE; MEZLOCILLIN; NETILMICIN; OFLOXACIN; PENICILLIN DERIVATIVE; PIPERACILLIN; QUINOLONE DERIVATIVE; TOBRAMYCIN;

ACUTE PANCREATITIS; ANTIBIOTIC PROPHYLAXIS; CONFERENCE PAPER; DRUG EFFICACY; DRUG PENETRATION; HUMAN; HUMAN CELL; HUMAN TISSUE; OUTCOMES RESEARCH; PRIORITY JOURNAL; SURGICAL DRAINAGE;

EID: 0030481727     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(96)00349-2     Document Type: Conference Paper

References (31)

1. Lumsden A, Bradley EL III. Secondary pancreatic infections. Surg Gynecol Obstet. 1990;170:459-67.
2. Bradley EL III. Antibiotics in acute pancreatitis. Current status and future directions. Am J Surg. 1989;158:472-7.
3. Pederzoli P, Bassi C, Vessentini S, Campedelli A. A randomized multicenter clinical trial of antibiotic prophylaxis of septic complications in acute necrotizing pancreatitis with impenem. Surg Gynecol Obstet. 1993;176:480-3.
4. Sainio V, Kempaineu E, Pvolakkainen P, et al. Early antibiotic treatment in acute necrotizing pancreatitis. Lancet. 1995;346:634-67.
5. Gross PA, Barrett TL, Dellinger EP, et al. Purpose of quality standards for infectious diseases. Clin Infect Dis. 1994;18:421.
6. Larvin MJ, McMahon MJ. APACHE II score for assessment and management of acute pancreatitis. Lancet. 1989:ii:201-4.
7. Vessintini S, Bassi C, Talamini G, et al. Prospective comparison of C-reactive protein level, Ranson score and contrast-enhanced computed tomography in the reduction of septic complications of acute pancreatitis. Br J Surg. 1993;80:755-7.
8. Gregg JA. Detection of bacterial infection of the pancreatic ducts in patients with pancreatitis and pancreatic cancer during endoscopic cannulation of the pancreatic duct. Gastroenterology. 1977; 73:1005-7.
9. Hershey SD, Sugawa C, Cushing R, et al. The value of prophylactic antibiotic therapy during endoscopic retrograde cholangiopancreatography. Surg Gynecol Obstet. 1982;155:801-3.
10. Foitzik T, Fernandez-Del Castillo C, Ferraro MJ, et al. Pathogenesis and presentation of early pancreatic infection in experimental acute necrotizing pancreatitis. Ann Surg. 1995;222:179-85.
11. Beger HG, Bittner R, Block S, Buchler M. Bacterial contamination of pancreatic necrosis. A prospective clinical study. Gastroenterology. 1986;91:433-8.
12. Bradley EL III. A fifteen-year experience with open drainage for infected pancreatic necrosis. Surg Gynecol Obstet. 1993;177:215-22.
13. Rattner DW, Legermate DA, Lee MJ, et al. Early surgical debridement of symptomatic pancreatic necrosis is beneficial irrespective of infection. Am J Surg. 1992;163:105-12.
14. Dellinger EP. Editorial Comment. Am J Surg. 1989;158:477-8.
15. Wyman JB, Bartholomew LG, Karlson AG, et al. Excretion of antibiotics in pancreatic juice: studies in dogs with normal pancreas and acute pancreatitis. Gastroenterology. 1967;53:930-40.
16. Studley JGN, Schentag JJ, Schenko WG Jr. Effect of bile induced pancreatitis on tobramycin excretion in pancreatic fluid. Ann Surg. 1981;193:649-53.
17. Traverso LW, MacFarlane SK. Pancreatic juice in the peritoneal cavity: antibiotics or omental preservation prevent mortality. J Surg Res. 1987;43:220-5.
18. Burns GP, Stein TA, Kabnick LS. Blood-pancreatic juice barrier to antibiotic excretion. Am J Surg. 1986;157:205-8.
19. Trudel JL, Wittnich C, Brown RA. Antibiotics bioavailability in acute experimental pancreatitis. J Am Coll Surg. 1994;178:475-9.
20. Mithofer K, Fernandez-Del Castillo C, et al. Antibiotic treatment improves survival in experimental acute necrotizing pancreatitis. Gastroenterology. 1996;110:232-40.
21. Brattstrom C, Malmborg A-S, Tyden G. Penetration of ciprofloxacin and ofloxacin into human allograft pancreatic juice. J Antimicrob Chemother. 1988;22:213-9.
22. Buchler M, Malfertheiner P, Friess H, et al. Human pancreatic tissue concentration of bactericidal antibiotics. Gastroenterology. 1992;103:1902-8.
23. Bassi C, Pederzoli P, Vesentini S, et al. Behavior of antibiotics during human necrotizing pancreatitis. J Antimicrob Chemother. 1994;830-6.
24. Craig RM, Dordal E, Myles L. The use of ampicillin in acute pancreatitis. Ann Intern Med. 1975;83:831-2.
25. Howes R, Zuidema GD, Cameron JL. Evaluation of prophylactic antibiotics in acute pancreatitis. J Surg Res. 1975;18:197-200.
26. Finch WT, Sawyers JL, Schenker S. A prospective study to determine the efficacy of antibiotics in acute pancreatitis. Ann Surg. 1976;183:667-71.
27. Wang X, Anderson R, Soltesz V, et al. Gut origin sepsis, macrophage function, and oxygen extraction associated with acute pancreatitis in the rat. World J Surg. 1996;20:299-308.
28. Gianotti L, Munda R, Gennari R, et al. Effect of different regimens of gut decontamination on bacterial translocation and experimental acute pancreatitis. Eur J Surg. 1995;161:85-92.
29. Luiten EJT, Hop WCJ, Lange JF, et al. Controlled clinical trial of selective decontamination for the treatment of severe acute pancreatitis. Ann Surg. 1995;222:57-65.
30. Bray HE, Brady CE. Antibiotics: an old issue in a new light. Am J Gasteroenterol. 1994;89:2275-6.
31. Oldach D. Antibiotic prophylaxis for necrotizing pancreatitis. Lancet. 1995;346:652.